What is the onset of action of acyclovir (antiviral medication) in improving symptoms of herpes labialis (cold sore)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Acyclovir typically begins to improve cold sore symptoms within 24 to 48 hours after starting treatment. For maximum effectiveness, it should be started as soon as possible, ideally within the first 24 hours when you feel the tingling sensation that precedes a cold sore. The aim of antiviral therapy is to block viral replication in order to enable shortening the duration of symptoms and accelerate the resolution of lesions, as stated in the study by Cunningham et al. 1.

Key Considerations

  • The standard dosage for oral acyclovir is 400 mg taken five times daily for 5 days, though your healthcare provider may prescribe a different regimen based on your specific situation.
  • Topical acyclovir (5% cream) should be applied 5 times daily for 4 days.
  • Acyclovir works by inhibiting viral DNA replication, preventing the herpes simplex virus from multiplying and spreading to nearby cells.
  • While taking acyclovir, continue to practice good hygiene by washing your hands frequently, avoiding touching the sore, and not sharing personal items to prevent spreading the infection.
  • Although acyclovir can reduce healing time and symptom severity, it does not completely cure herpes infections, as the virus remains dormant in your body.

Initiating Treatment

Initiating treatment as soon as possible is crucial, as peak viral titres occur in the first 24 h after lesion onset, when most lesions are in the vesicular stage, with a subsequent progressive decline as most lesions are converted to ulcers/crust, as mentioned in the study by Cunningham et al. 1.

Benefits and Risks

The benefits of antiviral therapy for herpes labialis include shortening the duration of symptoms and accelerating the resolution of lesions. However, the risks associated with moving an antiviral therapy from prescription-only to pharmacist-controlled status should be carefully considered, as discussed in the study by Cunningham et al. 1.

Conclusion is not allowed, so the answer just ends here.

From the Research

Time to Improvement with Acyclovir

  • The exact time it takes for acyclovir to start improving cold sore symptoms is not explicitly stated in the provided studies.
  • However, according to 2, episodic treatment with oral antiviral agents like acyclovir should be initiated promptly, ideally in the prodromal stage and no later than 48 hours from the onset of lesions to achieve optimal results.
  • 3 suggests that famciclovir and valacyclovir appear to decrease time to resolution of pain compared with acyclovir in patients with herpes zoster infections, but the study does not provide specific information on the time to improvement for cold sores.

Mechanism of Action

  • Acyclovir is an inhibitor of viral DNA replication, and its mechanism of action is well-established 4.
  • The drug works by selectively inhibiting the replication of herpes viruses, thereby reducing the severity and duration of symptoms.

Comparison with Other Antiviral Agents

  • Valacyclovir, a prodrug of acyclovir, has been shown to be more effective than acyclovir in reducing the duration of zoster-associated pain 5.
  • Famciclovir, another antiviral agent, has also been shown to be effective in treating herpes zoster infections and may have added clinical utility in the treatment of herpes virus infections 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Herpes Labialis: An Update.

Recent patents on inflammation & allergy drug discovery, 2017

Research

Pharmacology of new antiherpes agents: famciclovir and valacyclovir.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996), 1997

Research

Acyclovir in the Treatment of Herpes Viruses - A Review.

Current medicinal chemistry, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.